SCHEMBL10086784

SCHEMBL10086784

O=C(NCCOc1cccc(Cl)c1Cl)c1cnc2ccccn12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHB3 P54753 1/20 0.57
▸ LMNA P02545 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ KLKB1 P03952 1/20 0.49
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ RAB9A P51151 8/20 0.46
▸ NPC1 O15118 7/20 0.46
▸ KIT P10721 1/20 0.45
▸ DDR1 Q08345 1/20 0.45
▸ DDR2 Q16832 1/20 0.45
▸ TSHR P16473 2/20 0.44
▸ TP53 P04637 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10086803 0.82 NPC1 (0.56) EPHB3MAPTRAB9ANPC1KIT
SCHEMBL10086773 0.82 RAB9A (0.44) EPHB3LMNAMEN1KMT2ARAB9A
SCHEMBL1683591 0.82 KDM4E (0.50) EPHB3MEN1KMT2ARAB9ANPC1
SCHEMBL10086778 0.82 EPHB3 (0.45) EPHB3KMT2ARAB9ANPC1KIT
SCHEMBL1684347 0.80 RAB9A (0.50) EPHB3LMNAMAPTMEN1KMT2A
SCHEMBL9286069 0.79 EPHB3 (0.52) EPHB3MAPTRAB9ANPC1KIT
SCHEMBL9289501 0.79 EPHB3 (0.52) EPHB3MAPTRAB9ANPC1KIT
SCHEMBL29843826 0.77 EPHB3 (0.56) EPHB3LMNAMAPTRAB9ANPC1
SCHEMBL1682619 0.77 EPHB3 (0.46) EPHB3KLKB1RAB9ANPC1KIT
SCHEMBL10086770 0.77 EPHB3 (0.60) EPHB3LMNAMAPTKLKB1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012045729-A1 IMIDAZO [1, 2 -A] PYRIDINE AND PYRAZOLO [1, 5 -A] PYRIDINE DERIVATIVES AS TRPV1 ANTAGONISTS GLAXO GROUP LIMITED (GB) 2012-04-12 — — WO disclosed
Send feedback